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V
enous thromboembolism (VTE) is one of the most com-
mon, life-threatening cardiovascular conditions in the
United States, causing approximately 200,000 deaths each
year.
1,2 Hospitalized patients are particularly vulnerable to
VTE, with approximately 42.5% of all hospitalized medical
patients considered to be at increased VTE risk.
3 As a result,
multiple guidelines, including the prominent American College
of Chest Physicians Guidelines on Antithrombotic and Throm-
bolytic Therapy, support the administration of measures to
prevent VTE in appropriate patients.
4 Although pharmacologic
and, to a lesser degree, mechanical forms of prophylaxis, have
been shown to significantly reduce the risk of VTE
5, several
studies have shown that many hospitalized patients do not
receive VTE prophylaxis.
6–8 In this issue of the Journal of
General Internal Medicine, Rothberg et al. present a large
analysis of VTE prophylaxis rates among medical patients
admitted to 376 acute-care facilities in the United States,
finding that a striking 64% of patients with at least a moderate
risk of VTE failed to receive VTE prophylaxis by the second day
of their hospitalization.
9
Using an administrative database of greater than 350,000
medical inpatients with primary diagnoses indicating a mod-
erate to high-risk of VTE, this study revealed not only overall
low rates of VTE prophylaxis, but also considerable variability
in utilization rates across hospitals and providers. Despite
some differences in patient selection and definition of VTE
prophylaxis, the low administration rates are consistent with
other similar multi-institutional studies.
6,10,11 A unique find-
ing of the study was that, although prophylaxis rates varied
among individual physicians, physician practice seemed to
cluster around institutional means. Patients with similar VTE
risk profiles had widely divergent likelihoods of receiving VTE
prophylaxis depending on the admitting hospital, with vari-
ability observed by hospital size, type, and region. This
variation in clinical practice among hospitals suggests that
strategies aimed at improving prophylaxis rates should be
directed at the institutional level.
There are several limitations to this observational study
using administrative data. One is the lack of information on
clinical decision-making with regard to VTE prophylaxis, such
as contraindications to pharmacologic VTE prophylaxis or
patient preference. For example, a prior study found that
contraindications excluded 10% of medical patients from
receiving pharmacologic VTE prophylaxis.
6 It was possible that
some services may not have been consistently or uniformly
captured, as they were dependent on accurate billing and
utilization codes. Finally, using ICD-9 coded clinical diagnoses
to classify patients into varying levels of VTE risk may be
subject to misclassification and cannot completely capture the
unique circumstances of individual patients, such as comfort
care or highly ambulatory individuals who were thought to be
at low VTE risk.
Nevertheless, even allowing that some patients in this
analysis may not have required or desired VTE prophylaxis,
the low administration rates in the study still suggest that
significant numbers of patients fail to receive appropriate VTE
prophylaxis. That variation in prophylaxis administration
seemed to be more dependent on region and hospital practice
as opposed to individual patient factors highlights the need for
continued study in system-wide and institutionally-directed
interventions. The direction of further research should now
focus less on describing the scope of the problem and more on
how to best address barriers to quality improvement and most
effectively implement solutions.
STRATEGIES TO IMPROVE VTE PROPHYLAXIS
Expert panels, national quality organizations, and regulatory
bodies have aligned to address VTE prevention. The Joint
Commission, the National Quality Forum, the Centers for
Medicare & Medicaid Services, and the Agency for Healthcare
Research and Quality (AHRQ) have developed measure-based
initiatives such as quality indicators, public reporting, and
incentive and disincentive programs targeting VTE prophylaxis
rates. These have provided the impetus for national collabora-
tives such as the Society of Hospital Medicine (SHM) VTE
Prevention Collaborative
12 and the incorporation of VTE
prophylaxis in the Surgical Care Improvement Project (SCIP).
The Surgeon General issued a “Call to Action to Prevent Deep
Venous Thrombosis and Pulmonary Embolism” in 2008,
further emphasizing VTE prevention as a major public health
concern.
13 Despite efforts from leading regulatory and quality
improvement agencies to promote awareness and motivation
for VTE prophylaxis, as well as clear evidence that the impact
of VTE prevention efforts can be large, what seem to be
straightforward interventions are frequently challenging to
implement in actual practice.
14
The simplest but probably least effective strategy is attempt-
ing to change practice through passive methods such as the Published online February 14, 2010
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484development and publication of guidelines. Although guide-
lines are vital in summarizing best practice recommendations
and expert opinion, even well-known guidelines, such as those
recommending VTE prophylaxis, face multiple barriers in
terms of assimilation into clinical practice.
9,15–17 The dissem-
ination of locally specific recommendations can be more
effective, particularly as part of a multipronged strategy.
18
More active strategies, such as targeted education about
VTE prophylaxis,
19 have shown effectiveness in improving VTE
prophylaxis but are limited in reach and retention over time.
Relying on individual clinicians to remember and apply
information correctly at each clinical encounter is inefficient
and frequently ineffective. An important area for further
research should be directed in how to best implement ‘micro’
level (i.e., at the point of care) interventions to assist providers
at the time of the clinical encounter so as to encourage specific
behaviors. Examples of micro-level interventions that have
been shown to improve VTE prophylaxis rates include auto-
mated reminder systems such as computer alerts
20 and
protocols embedded in admission and transfer order sets.
20
Computer alerts have been shown to improve VTE prophylaxis
ordering rates
23,24 and were associated with a 41% reduction
in the 90-day incidence of VTE in one study.
20 Successful
strategies acknowledge that clinical care is complex and fast-
paced, and attempt to integrate interventions into usual
clinical workflow. Interventions that embed VTE prophylaxis
into standardized, pre-existing order sets are more effective
than asking physicians to complete separate, free-standing
VTE-specific order sets.
12 Simple interventions such as check-
lists may also be effective, having been shown to dramatically
improve clinical outcomes in other settings such as reducing
catheter-related blood stream infections
21, postoperative com-
plications, and surgery-related deaths.
22
Enhancing clinical decision-support through building in
reminder-systems and evidence-based recommendations into
computerized order sets and electronic medical records, has
great potential.
25 A 2005 meta-analysis of such systems found
improvements in specific processes of care 62% of the time,
though only 13% showed improved patient outcomes. Barriers
to effective use included poor workflow integration, misaligned
relevance to patients at the point of care, and provider
disagreement with recommendations.
25–27 Importantly, the
variability in uptake of computerized medical record systems
as well as the heterogeneity in decision-support capability
across specific institutions are barriers to widespread adoption
of this strategy at present.
Measurement, through real time audit and feedback, is an
essential component of any improvement strategy. Combining
audit and feedback with other effective strategies such as
reminder systems and decision support at the point of care, have
been shown to improve VTE prophylaxis to near 100%.
12
However, there are numerous challenges in being able to collect
data in real time such that individual providers can respond to
audit and feedback. One such intervention, the use of a ‘quality
dashboard’ toprovidesummaryreportsofpredeterminedclinical
measures, is an example of a specific tool that can contribute to
the success of high performing institutions.
28 Quality dash-
boards can help hospital leadership guide the quality agenda,
create accountability for high-priority measures
29 and provide
actionable information to effect change at the point-of-care.
30
Finally, catalyzing real improvement across institutions
would benefit from the adoption of general frameworks of
effective quality improvement strategies. One example is the
VTE Prevention Collaborative supported by the Society of
Hospital Medicine, the Institute for Healthcare Improvement,
and AHRQ.
12 This collaborative seeks to disseminate effective
strategies shown to improve VTE care as well as provide
guidance and mentorship to individual hospitals at the local
level to help address barriers to implementation
12.B yp o o l i n g
knowledge and best practices, providing specific toolkits for
quality improvement, and tailoring solutions to local insti-
tutional culture, such initiatives help disseminate effective
solutions and reduce duplication of efforts. Identifying
characteristics of high-performing institutions can provide
templates for other hospitals to model their efforts. Features
of high-performing institutions include a culture that welcomes
quality improvement and change, supports and retains individ-




Significant numbers of hospitalized patients in the United
States fail to receive appropriate VTE prophylaxis despite clear
guidelines and widespread efforts to raise VTE awareness. The
study by Rothberg et al. highlights the magnitude and
widespread nature of the problem, as well as the wide
variability in practice across different institutions
9. Efforts
should now focus on disseminating effective strategies to
change clinical practice, both at the point of care and
institutional level, and seek out high-performing institutions
as models of effective practice change.
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